News:
Deutsch (DE-CH-AT)
Research
  • TOC 1: Splicing in Ovarian Cancer
  • TOC 2: Companion Protocol Topo weekly
  • TOC 3: Prediction of the surgical outcome using Gene expression analysis and Metabolomics
  • TOC 5: PAI-RBP1 (SERBP1) and PAI-1 in primary and recurrent ovarian cancer
  • TOC 6: Validierung von DNA-Methylierungsmarkern zur Prognosevorhersage von Ovarialkarzinomen
  • OVCAD Multicentric EU-project. www.ovcad.eu
  • New prognostic and predictive markers for early ovarian cancer patients from ACTION Trial(Adjuvant ChemoTherapy In Ovarian Neoplasm). TOC-EORTC Translational Research
  • Project.Predictor-Study: "Diagnostische Genauigkeit von In-vitro-Diagnostika für die Vorhersage eines Therapieansprechens bei Patientinnen mit Ovarialkarzinom-Rezidiv".
  • In vitro Studie von catumaxumab bei Patientinnen mit Ovarialkarzinome

 

 

ISO 9001 Certified

In the process of the certification for European Competence Center for Ovarian Cancer, in 2007 and 2008 TOC was also certified by the TÜV Süd (ISO 9001)
RocketTheme Joomla Templates